School of Integrated Health Sciences News
With many degree offerings that are accredited by national organizations, the School of Integrated Health Sciences offers dynamic classroom instruction, laboratory/clinical practice, research, and mentoring. Our students develop skills that help them break into health-related fields and further their graduate or professional studies.
Current Integrated Health Sciences News
With the value of community impressed upon him at the School of Integrated Health Sciences, Nikkita Crozier builds career with U.S. Public Health Service.
UNLV Brain Health researcher Lina Nih is developing a treatment that could one day alter how practitioners address stroke recovery.
An enduring UNLV end-of-semester tradition is to highlight exceptional students who embody the academic, research, and community impact of the graduating class.
This month’s frosty headlines and highlights from the students and faculty of UNLV.
Approach aimed at lifting Nevada from its low rankings in health care access.
Embracing the idea that we’re “better together,” UNLV’s academic health center takes another step forward.
Integrated Health Sciences In The News
If you get a period, you may have noticed that your body feels…different…at various points in your monthly cycle. Some days, you might feel charged up and ready to go, while others you’re moving in slow motion. It would make sense that this ebb and flow might impact how you show up to tackle your fitness routine too. That’s the idea behind cycle-syncing workouts, or the practice of changing up your exercise routine according to what phase you’re at in your menstrual cycle.
The humble potato, often associated with high-fat foods due to its fried preparation, has been vindicated by a study from the University of Nevada, Las Vegas (UNLV). According to the results, this tuber, when eaten baked and with its skin, can benefit cardiovascular health in people with type 2 diabetes.
Is walking backwards, also known as retro walking, a fitness trend you should be trying — assuming you’re willing to get a few quizzical looks from friends and neighbors?
Axsome’s expectation that AXS-05 can win market share from Rexulti is partly built on the belief that the drug candidate has a differentiated safety profile. Rexulti has a boxed warning because of an increased risk of death. There were no deaths in the AXS-05 trials. Jeffrey Cummings, a research professor at the University of Nevada, Las Vegas, discussed what may happen if AXS-05 avoids a boxed warning.
Axsome Therapeutics said on Monday it would seek marketing approval next year for its oral drug to treat agitation in patients with Alzheimer’s disease, after it succeeded in three out of four late-stage studies.
Today, Axsome will host a conference call and webcast to discuss these topline results. Dr. Jeffrey Cummings, Vice Chair of Research at UNLV Department of Brain Health, will join the call and be available for questions.